Stockscreener 앱 받기
91.09
0.82%
-0.75
시간 외 거래:
91.31
0.22
+0.24%
전일 마감가:
$91.84
열려 있는:
$91.57
하루 거래량:
121.91K
Relative Volume:
1.04
시가총액:
$1.16B
수익:
$86.28M
순이익/손실:
$23.61M
주가수익비율:
49.62
EPS:
1.8359
순현금흐름:
$23.97M
1주 성능:
-5.11%
1개월 성능:
+5.38%
6개월 성능:
-3.12%
1년 성능:
+57.11%
1일 변동 폭
$89.69
$93.69
1주일 범위
$89.69
$97.98
52주 변동 폭
$55.11
$107.90
Iradimed Corp Stock (IRMD) Company Profile
명칭
Iradimed Corp
전화
(407) 677-8022
주소
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
91.09 | 1.16B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-04-12 | 개시 | Lake Street | Buy |
| 2017-10-31 | 재개 | ROTH Capital | Buy |
| 2016-10-05 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2015-11-02 | 재확인 | ROTH Capital | Buy |
| 2015-07-30 | 재확인 | ROTH Capital | Buy |
| 2015-06-16 | 재확인 | ROTH Capital | Buy |
| 2015-01-12 | 재확인 | ROTH Capital | Buy |
| 2014-12-23 | 재확인 | ROTH Capital | Buy |
모두보기
Iradimed Corp 주식(IRMD)의 최신 뉴스
IRADIMED CORP (IRMD) Stock Chart - ChartMill
Number of shareholders of IRadimed Corp. – DUS:46K - TradingView
Iradimed director sells $285,000 in company stock By Investing.com - Investing.com Australia
Insider Sell: Hilda Scharen-guivel Sells 3,000 Shares of iRadimed Corp (IRMD) - GuruFocus
Iradimed director sells $285,000 in company stock - Investing.com UK
IRADIMED (IRMD) director sells 3,000 shares in open-market trades - Stock Titan
IRMD (NASDAQ: IRMD) files notice to resell 285,000 common shares - Stock Titan
Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple - Yahoo Finance
Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares - Investing.com
Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares By Investing.com - Investing.com India
IRADIMED (IRMD) CEO-linked trust sells 2,500 shares under 10b5-1 plan - Stock Titan
IRADIMED CEO Sells 7500 Common Stock Shares - asatunews.co.id
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - Yahoo Finance
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - The Motley Fool
Iradimed Corp Quarterly Report Highlights Key Growth DriversEarnings Call Q&A - The Legal Advocate
Iradimed Reports 13 Percent Revenue Growth in First Quarter of 2026 - HarianBasis.co
IRMD Q1 2026 Earnings: EPS Beat of 7.95% Sends Stock LowerPeak Earnings Alert - newsline.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares in 10b5-1 plan - Stock Titan
Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report - Insider Monkey
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors? - sharewise.com
iRadimed (IRMD) Slips Amidst Sector Headwinds: Key Levels in FocusSweep Order Flow - The Legal Advocate
IRadimed’s Earnings Call Highlights 3870-Led Growth - TipRanks
iRadimed Corp (IRMD) Rallies 3% as Medical Device Stock Holds Key SupportOpen Market Insights - Newser
Iradimed CEO Roger Susi sells $657,264 in company stock By Investing.com - Investing.com Australia
Iradimed CEO Roger Susi sells $657,264 in company stock - Investing.com
CEO’s trust sells 7,500 IRADIMED (IRMD) shares under Rule 10b5-1 plan - Stock Titan
IRADIMED CEO and CFO head to Goldman Sachs health conference in Miami - Stock Titan
iRadimed Corporation (IRMD) Crushes Q1 2026 Estimates — EPS $0.49 Tops ViewsEarnings Revision Downgrade - The Legal Advocate
Iradimed (NASDAQ: IRMD) family trusts disclose 4.45M shares, 34.8% ownership - Stock Titan
IRADIMED (IRMD) CEO Susi’s trust sells 7,500 pre-planned shares - Stock Titan
Reaffirmed Outlook And Dividend: What Does IRMD’s Confidence Signal About Its MRI Pump Moat? - Yahoo Finance
The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 GuidanceLearn Why - Sahm
TradingKey - TradingKey
Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend - Yahoo Finance
IRMD (iRadimed Corporation) beats Q1 estimates with 14.4% revenue growth, but shares dip despite strong results.Attention Driven Stocks - Newser
A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness - Yahoo Finance
Iradimed CEO Roger Susi sells $642,861 in company stock By Investing.com - Investing.com South Africa
Iradimed CEO Roger Susi sells $642,861 in company stock - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under 10b5-1 plan - Stock Titan
Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD? - Sahm
IRadimed Corporation (NASDAQ:IRMD) Q1 2026 Earnings Call Transcript - Insider Monkey
IRadimed Rides 3870 Momentum Despite Near-Term Dip - TipRanks
Iradimed Corp (IRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):